Polypharmacy and sustainable developmental goals: linking evidence-based medicine, patient engagement, and shared decision-making

Renal Replacement Therapy

卷:9

Review

Yasuhiro Komatsu¹ 

[1] Department of Healthcare Quality and Safety, Gunma University Graduate School of Medicine, Gunma, Japan;

关键词: Polypharmacy;    Evidence-based medicine;    Patient engagement;    Shared decision-making;    Sustainable Development Goals;   

DOI  :  10.1186/s41100-023-00474-3

 received in 2022-11-14, accepted in 2023-04-11,  发布年份 2023

来源: Springer

【 摘 要 】

Sustainable Development Goals (SDGs) are an urgent call for action adopted by the United Nations to improve health and education, reduce inequality, and spur economic growth. The SDG 3 objective of good health and well-being is fundamentally linked to patient safety. Medication safety is a crucial issue in the promotion of health and well-being, and polypharmacy management is a key challenge in medication safety. Inappropriate polypharmacy can increase adverse drug events and health expenditures and reduce patient quality of life. As such, polypharmacy is prominent among older adults with chronic kidney disease. Optimal medication practice requires a high level of evidence-based medicine that integrates both scientific best evidence and patient values and preferences through a shared decision-making process. This article reviews polypharmacy management based on patient engagement and shared decision-making.

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

Fig. 3

Fig. 2

Fig. 1